Investment Details
Investor Type
Venture Capital
Asset Class Focus
Biotechnology, Medical Device, Healthcare
Stage Focus
Early Stage Venture, Series A, Series B, Growth Stage
Geographical Focus
United States, United Kingdom, Germany, France, Italy, United Arab Emirates, Switzerland, Spain, Luxembourg, Saudi Arabia, Qatar, Kuwait, Egypt, Morocco, Algeria, Lebanon, Turkey, Jordan, Netherlands, Belgium
Industries Focus
- Healthcare
- Real Estate
- Asset Management
- Sustainability
- Medtech
- Biotechnology
- Cleantech
- GreenTech
- Renewables
- Medical Device
- Chemical
- SME
Investment Size:
10,000,000 to 50,000,000 USD
Investor Details Founded: 2010
Valquest Partners is a venture capital firm investing in innovative companies in the life sciences industry.
The firm focuses on early-stage investments, particularly in biotechnology, medical devices, and healthcare sectors. It has a strong presence in Europe and the MENA region, with investments in countries such as France, Lebanon, Switzerland, and the United States.
Valquest Partners has a track record of supporting companies like TISSIUM, a Paris-based medical device company specializing in biodegradable programmable polymer technology for tissue reconstruction and surgical wound closure. The firm also invested in Bloom Biorenewables Ltd, a Swiss company developing technologies to convert wood and agricultural waste into renewable materials.
Requirements
- Innovative companies in the life sciences industry
- Early-stage ventures
- Biotechnology, medical device, and healthcare sectors
Contact
[Official Website Hidden]
[HQ Location Hidden]
Portfolio Companies
- Tissium
- Bloom Biorenewables Ltd
Mentioned In
-
$19.95
-
$19.95
-
$24.95
-
$24.95
-
$24.95
-
$24.95
-
$14.95
-
$24.95
-
$19.95
-
$19.95
-
$14.95
-
$14.95
-
$14.95
-
$99.00
-
$24.95
-
$19.95
-
$19.95
-
$49.95
-
$19.95
-
$9.95
Claim this Investor
Are you an official representative of Valquest Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim